Search result for Ocon
Important development: FEMTECH subsidiary OCON Healthcare of the Merchavia Investments Group inked an exclusive deal with BioGenuine
The Israeli FEMTECH company OCON Healthcare, part of the Merchavia Holdings and Investments (TASE: MRHL) group of companies, has announced that it has reached a legally binding agreement with BioGenuine, a Chinese pharmaceutical company specialising in women's health. BioGenuine will start ma...
STUDY ESTIMATES SEROPREVALENCE OF SARS-COV-2 ANTIBODIES IN SOUTHERN ITALIAN POPULATION
HIGHLIGHTS
- A study has estimated seroprevalence of SARS-CoV-2 antibodies in Southern Italian Population.
- Most people covered in the study are adults and healthcare workers.
Recently, a study was carried out to estimate the seropreval...
BENEFITS OF COCONUT OIL TO IMPROVE YOUR HEALTH
Highlights:
- Different types of health benefits of coconut oil for the improving the health of a person
- Coconut oil has been reportedly one of the healthiest foods people can find across the world
Coconut oil has been reportedly one o...
COCONUT WATER: NO LESS THAN MAGIC POTION ON THE EARTH
Highlights
• Unlike other fruit juices, coconut water is readily available and doesn’t require any extra sugar for taste
• Similarly, unflavored coconut water is low in sugar and calories, while other fruit juices have twice the number of calories in unflavored...
ASEAN-KOREA CENTRE INTRODUCES AWARDS FOR 4 EXCEPTIONAL STARTUPS TO NURTURE GROWTH
- The ASEAN-Korea Centre, in a joint venture with the Gyeonggi Center for Creative Economy and Innovation (GCCEI), called out the four most outstanding companies, Dec. 3, in an annual event to support startups from ASEAN and Korea with the only aim being, to encourage investment and mutual ...
NIPPON TELEGRAPH AND TELEPHONE CORP. TO MAKE NTT DOCOMO INC. A FULLY OWNED UNIT
Highlights –
- Nippon Telegraph and Telephone Corp. to make NTT Docomo Inc. a fully owned unit.
- Nippon Telegraph and Telephone Corp. plans to do so through a tender offer.
- The plan will be discussed at their respective board meetings.<...
INDIA’S COVID-19 TALLY AT 27,02,742, DEATH TOLL GOES UP TO 51,797
• Current Total Cases: 2,702,742
• Total Deaths : 51,797
• Cumulative recoveries : 1,977,779
• Active cases: 673,166
• Top five states that has the maximum number of cases :
Maharashtra: Cases 604,358, number of deat...
NATIONAL REFORESTATION PROGRAM TAKES OFF IN THAILAND; COCONUT INDUSTRY PLUNGES AFTER PETA ACCUSATION
HIGHLIGHTS
NATIONAL REFORESTATION
- A national reforestation program got kicked off in the presence of Prime Minister Prayut Chan-o-Cha in the north side province. The nationwide reforestation venture meant to extend forest areas at a ra...
PETA CALLS FOR BAN ON COCONUT PRODUCTS HARVESTED FROM MONKEYS
HIGHLIGHTS
- Thailand is well-known for coconut exports to western countries
- They train monkeys to get the coconuts from the trees
American organization for animals has declared a ban on Thailand coconut industry, calling it a harvest ...
BIOCON'S SYNGENE CLAIMS OF DEVELOPING NEW COVID TECHNOLOGY
Highlights
• Syngene is ready with the technology and will soon send it to the National Institute of Biologicals (NIB) in order to get an approval
• According to executive chairperson Kiran Mazumdar-Shaw, the cost of a test will not exceed Rs 250
• Bio...
COCONUT WATER: WHY IS IT BENEFICIAL?
Highlights
- It is loaded with the natural goodness of nutrients
- Is excellent as a hydrating drink
- Aids in lowering blood pressure
A tropical fruit, coconut water has been the recommended cure for indigestion, and dehydrati...
Ocon to test for Renault from December 2
Formula one season is nearing its end for the 2019 season and the drivers market is already full with Estaban Ocon taking the seat of Nico Hulkenberg and Nicholas Latifi coming in the Williams racing team in place of Robert Kubica and the other teams more or less keeping their driver line up inta...
Biocon's future focus on making processes robust and GMP compliance
As the chair at the helm of Biocon changes face, there is a new zeal to increase the efforts in making the processes more robust and to make them free from excessive human interference. The company is embarking on a digital journey from the quality control and process control point of view, which...
Biocon, Mylan launch hormone biosimilar in Australia
Biotechnology major Biocon, and company Mylan N V announced the launch of their hormone biosimilar for the treatment of the polygenic disorder, in Australia.
“We are extraordinarily excited to alter reasonable access to Semglee, a high-quality biosimilar hormone glargine, co...